MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03153naaaa2200409uu 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
https://directory.doabooks.org/handle/20.500.12854/73697 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220714183211.0 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-2-88963-545-0 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9782889635450 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.3389/978-2-88963-545-0 |
| Terms of availability |
doi |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
dc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
PD |
| Source |
bicssc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MMG |
| Source |
bicssc |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gerosa, Maria |
| Relator code |
edt |
| 9 (RLIN) |
1602652 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
New Therapies in the Field of Rheumatology |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Name of publisher, distributor, etc |
Frontiers Media SA |
| Date of publication, distribution, etc |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 electronic resource (144 p.) |
| 506 0# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Open Access |
| Source of term |
star |
| Standardized terminology for access restriction |
Unrestricted online access |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
In recent years, the long term prognosis of patients with rheumatic disease has dramatically improved, due to the enormous advances in the understanding of the pathogenesis of these diseases that have led to the development of drugs targeting the molecules directly involved in the inflammatory response. The development of these biological drugs has radically changed the therapeutic approach of inflammatory rheumatic diseases, mainly in patients resistant to standard treatment. Also in the field of conventional therapy, many new data have confirmed the effectiveness of "old" drugs, such as hydroxychloroquine, methotrexate and azathioprine, demonstrating several additional beneficial properties for the treatment of Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) or other autoimmune diseases. Moreover, immunosuppressant developed to prevent graft rejection such as mycophenolate or tacrolimus have been demonstrated to have an important role in the treatment of rheumatic patients. Beside the well defined anti-inflammatory properties of biological and synthetic anti-rheumatic drugs, a number of additional beneficial effects have been suggested, that have been hypothesized to prevent long term complications of autoimmune diseases, such as accelerated atherosclerosis, increased cardiovascular risk and osteoporosis. This Research Topic collects new information regarding safety and effectiveness of new and old drugs for the treatment of RA, SLE, or other autoimmune diseases. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
|---|
| Terms governing use and reproduction |
Creative Commons |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| -- |
cc |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Science: general issues |
| Source of heading or term |
bicssc |
| 9 (RLIN) |
101510 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology |
| Source of heading or term |
bicssc |
| 9 (RLIN) |
69517 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
autoimmune diseases |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
rheumatoid arthritis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
systemic lupus erythematosus |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
disease modifing anti- rheumatic drugs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
biological therapies |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Beatrice Chighizola, Cecilia |
| Relator code |
edt |
| 9 (RLIN) |
1602653 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Jakobsson, Per-Johan |
| Relator code |
edt |
| 9 (RLIN) |
1602654 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gerosa, Maria |
| Relator code |
oth |
| 9 (RLIN) |
1602652 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Beatrice Chighizola, Cecilia |
| Relator code |
oth |
| 9 (RLIN) |
1602653 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Jakobsson, Per-Johan |
| Relator code |
oth |
| 9 (RLIN) |
1602654 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://www.frontiersin.org/research-topics/7952/new-therapies-in-the-field-of-rheumatology">https://www.frontiersin.org/research-topics/7952/new-therapies-in-the-field-of-rheumatology</a> |
| -- |
0 |
| Public note |
DOAB: download the publication |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/73697">https://directory.doabooks.org/handle/20.500.12854/73697</a> |
| -- |
0 |
| Public note |
DOAB: description of the publication |
